Investing Profile

Tim Kutzkey

InvestorVC
Managing Partner at The Column Group
thecolumngroup.com/member/tim...San Francisco, California
Photo of Tim Kutzkey, Managing Partner at The Column Group
Your Intro Paths to Tim Kutzkey

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Tim is a member of
Stanford University Network
507 CONNECTIONS
University of California, Berkeley Network
246 CONNECTIONS
UC Berkeley Network
15 CONNECTIONS

Find Tim Kutzkey on

cb
Current Investing Position
The Column Group Managing Partner
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
13
Current Fund Size
$600M

Tim Kutzkey is on these Sector & Stage Rankings

Pharmaceuticals (Series B)Pharmaceuticals (Seed)Pharmaceuticals (Series A)Consumer Health (Series B)Digital Health (Series B)BioTech (Series B)Pharmaceuticals (Series B)Health & Hospital Services (Series B)Consumer Health (Series B)Pharmaceuticals (Series A)Health IT (Series B)Consumer Health (Series A)Pharmaceuticals (Seed)Consumer Health (Seed)Digital Health (Series A)Digital Health (Seed)BioTech (Series A)Health & Hospital Services (Seed)Health & Hospital Services (Series A)BioTech (Seed)Consumer Health (Series A)BioTech (Series B)Health IT (Seed)Health IT (Series A)Health IT (Series B)Digital Health (Series B)Digital Health (Series A)Consumer Health (Seed)Health & Hospital Services (Series B)BioTech (Seed)BioTech (Series A)Digital Health (Seed)Health IT (Series A)Health IT (Seed)Health & Hospital Services (Seed)Health & Hospital Services (Series A)San Francisco Bay Area

Tim Kutzkey's Investments On Record (8)

CompanyStageDateRound SizeTotal Raised
Atavistik Bio
Series UnknownDec 2023$40M
Series AAug 2021$60M
$100M
Co-investors: Josh Wolfe (Lux Capital Management), Thilo Schroeder (Nextech Invest), John Josey (The Column Group), Jeff Goater (The Column Group)
Kimia Therapeutics
Series ADec 2023$55M
$55M
Synthekine
Series CJan 2023$100M
Series BJun 2021$110M
Series ASep 2020$82M
$290M
Co-investors: Julie Grant (Canaan Partners)
Cajal Neuroscience
Series ANov 2022$96M
$96M
Co-investors: Adam Goulburn (Lux Capital Management), Ian Peikon (Lux Capital Management), Josh Wolfe (Lux Capital Management)
Plexium
Series BFeb 2022$100M
$140M
Co-investors: Adam Goulburn (Lux Capital Management), Kiersten Stead (DCVC (Data Collective)), Rob Hopfner (Pivotal bioVenture Partners)
Kallyope
Series DFeb 2022$240M
$480M
Co-investors: Josh Wolfe (Lux Capital Management), Tony Evnin (Venrock), Bill Gates
Surrozen
Series CJun 2020$50M
Series BMar 2019$50M
Series AFeb 2017$33M
$130M
Cyterix Pharmaceuticals
Series AJun 2011$9M
$9M

Tim Kutzkey's Experience

Managing Partner The Column Group2007 - Present
Scientist KAI Pharmaceuticals2006 - 2007
Post-doc UC Berkeley2005 - 2006

Tim Kutzkey's Education

University of California, Berkeley Ph.D. Molecular and Cell Biology
Stanford University